Afine Chemicals Limited
Assessed Supplier Enterprise Certification
- Assessed
Supplier - 14th
years
Assessed Supplier Enterprise Certification
Product Certification&
Enterprise Certification
Country: 
China (Mainland)
Business Type:Lab/Research institutions
Tel: +86-571-85134551
Mobile:
Tel: +86-571-85134551
Fax: +86-571-85134895
Province/state: zhejiang
City: Hangzhou
Street: No. 206 Zhen Hua Road, Hangzhou 310030, Zhejiang, China
MaxCard:
Contact Suppliers
CAS NO.1985605-59-1
Our Services
1. New Molecules R&D
2. Own test center HPLC NMR GC LC-MS
3. API and Intermediates from China reputed manufacturers
4. Documents support COA MOA MSDS DMF open part
Our advantages
1. Government awarded company. Top 100 enterprises in Hangzhou
2. Quality warrant. If any quality failure. we 100% return the payment or replacement
3.More than 14 years experiences in pharmaceutical and chemical international trading
4.Fast response on customers request and fast shipment
Baloxavir is a third-generation anti-influenza chemical, originally developed by Shiono Pharmaceutical Co., LTD., and globally developed by Roche. Chemicalbook is the first single-dose oral Chemicalbook to be approved by the U.S. Food and Drug Administration (FDA) in nearly 20 years. Chemicalbook is the first single-dose oral Chemicalbook that has A novel antiviral mechanism of action against influenza A and B viruses. Including tamiflu (oseltamivir) resistant strains of influenza and avian influenza (H7N9, H5N1). The study showed that the new drug was effective in a single oral administration in patients over 12 years of age with acute flu symptoms lasting less than 48 hours.
Baloxavir is a drug employed in the treatment of influenza virus infection.
Baloxavir marboxil is a selective inhibitor of influenza cap-dependent endonuclease. It has shown therapeutic activity in preclinical models of influenza A and B virus infections, including strains resistant to current antiviral agents.
| Baloxavir Chemical Properties |
| Boiling point | 644.7±65.0 °C(Predicted) |
| density | 1.63±0.1 g/cm3(Predicted) |
| pka | 4.50±1.00(Predicted) |
| CAS DataBase Reference | 1985605-59-1 |
Company Introduction
1. Established in 2005, with two independent business divisions: Fine chemicals division; Pharmaceutical division.
a. "Top 100 innovation-oriented export enterprises Of Hangzhou" honored by Hangzhou government
b. Specialized in the fine chemicals and pharmaceuticals
c. A leading manufacturer and trader of APIs in China
2. Main product:(Pharmaceutical division)
· Pharmaceutical active ingredients
·
· Pharmaceutical intermediates
·
· custom synthesis
